Neuroligin-derived peptides

Biomarker

1 paper2 findings

  • Humans1

Upstream

1

Cognitive impairment

upin humans1

1 study
  1. Cognitive impairment increases neuroligin-derived peptides in humans.

    “levels of specific NLGN peptides were significantly elevated in CI compared to CN individuals.”

    Humanscognitively impaired vs cognitively normal individualsplasma

    Differences in blood levels of neuroligin-derived peptides in a cohort for early detection of Alzheimer's disease

    The journals of gerontology. Series A, Biological sciences and medical sciences5 Feb 2026

More on Cognitive impairment

Associations

1

MAPT

upin humans1

1 study
  1. MAPT is associated with neuroligin-derived peptides in humans.

    “specific plasma phosphorylated tau peptides were significantly and positively correlated with selected NLGN-derived peptides in more advanced stages of cognitive decline.”

    Humansmore advanced stages of cognitive declineplasma

    Differences in blood levels of neuroligin-derived peptides in a cohort for early detection of Alzheimer's disease

    The journals of gerontology. Series A, Biological sciences and medical sciences5 Feb 2026

More on MAPT

Latest

Nov 2025: 0Dec 2025: 0Jan 2026: 0Feb 2026: 1Mar 2026: 0Apr 2026: 0May 2026: 0Jun 2026: 0Jul 2026: 0Aug 2026: 0Sep 2026: 0Oct 2026: 01 in 12 months